Prevalence and Associated Factors of Suboptimal Daily Peak Inspiratory Flow and Technique Misuse of Dry Powder Inhalers in Outpatients with Stable Chronic Airway Diseases

References

• Global strategy for asthma management and prevention. 2020. Available from: https://ginasthma.org. Accessed December 3, 2020.
   Google Scholar
• Global initiative for chronic obstructive lung disease. 2021. Available from: https://goldcopd.org/2021-gold-reports/. Accessed December 3, 2020.
   Google Scholar
• Ghosh S, Ohar JA, Drummond MB. Peak inspiratory flow rate in chronic obstructive pulmonary disease: implications for dry powder inhalers. J Aerosol Med Pulm Drug Deliv. 2017;30(6):381–387. doi:10.1089/jamp.2017.1416
   PubMed Web of Science ®Google Scholar
• Chen SY, Huang CK, Peng HC, Yu CJ, Chien JY. Inappropriate peak inspiratory flow rate with dry powder inhaler in chronic obstructive pulmonary disease. Sci Rep. 2020;10(1):7271. doi:10.1038/s41598-020-64235-6
   PubMed Web of Science ®Google Scholar
• Westerik JA, Carter V, Chrystyn H, et al. Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting. J Asthma. 2016;53(3):321–329. doi:10.3109/02770903.2015.1099160
   PubMed Web of Science ®Google Scholar
• Li H, Chen Y, Zhang Z, Dong X, Zhang G, Zhang H. Handling of diskus dry powder inhaler in Chinese chronic obstructive pulmonary disease patients. J Aerosol Med Pulm Drug Deliv. 2014;27(3):219–227. doi:10.1089/jamp.2012.1033
   PubMed Web of Science ®Google Scholar
• Zhang QL, Zheng JP, Pan WH, et al. [Peak inspiratory flow generated through different analogue dry powder inhalers in Shenzhen healthy preschool children]. Zhonghua Er Ke Za Zhi. 2008;46(2):98–103. [Chinese].
   PubMedGoogle Scholar
• Sanders MJ. Guiding inspiratory flow: development of the in-check DIAL G16, a tool for improving inhaler technique. Pulm Med. 2017;2017:1495867. doi:10.1155/2017/1495867
   PubMed Web of Science ®Google Scholar
• The use of inhaler devices in adults. Uptodate, Inc; 2020.
   Google Scholar
• Laube BL, Janssens HM, de Jongh FHC, et al. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J. 2011;37:1308–1331. doi:10.1183/09031936.00166410
   PubMed Web of Science ®Google Scholar
• Chodosh S, Flanders JS, Kesten S, Serby CW, Hochrainer D, Witek TJ. Effective delivery of particles with the HandiHaler dry powder inhalation system over a range of chronic obstructive pulmonary disease severity. J Aerosol Med. 2001;14(3):309–315. doi:10.1089/089426801316970268
   PubMedGoogle Scholar
• de Boer AH, Bolhuis GK, Gjaltema D, Hagedoorn P. Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers: part 3: the effect of flow increase rate (FIR) on the in vitro drug release from the Pulmicort 200 Turbuhaler. Int J Pharm. 1997;153(1):67–77. doi:10.1016/S0378-5173(97)00097-5
   Web of Science ®Google Scholar
• Borgstrom L, Bondesson E, Moren F, Trofast E, Newman SP. Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects. Eur Respir J. 1994;7(1):69–73. doi:10.1183/09031936.94.07010069
   PubMed Web of Science ®Google Scholar
• Hill LS, Slater AL. A comparison of the performance of two modern multidose dry powder asthma inhalers. Respir Med. 1998;92(1):105–110. doi:10.1016/S0954-6111(98)90040-3
   PubMed Web of Science ®Google Scholar
• Al-Showair RA, Tarsin WY, Assi KH, Pearson SB, Chrystyn H. Can all patients with COPD use the correct inhalation flow with all inhalers and does training help? Respir Med. 2007;101(11):2395–2401. doi:10.1016/j.rmed.2007.06.008
   PubMed Web of Science ®Google Scholar
• Janssens W, VandenBrande P, Hardeman E, et al. Inspiratory flow rates at different levels of resistance in elderly COPD patients. Eur Respir J. 2008;31(1):78–83. doi:10.1183/09031936.00024807
   PubMed Web of Science ®Google Scholar
• Loh CH, Peters SP, Lovings TM, Ohar JA. Suboptimal inspiratory flow rates are associated with chronic obstructive pulmonary disease and all-cause readmissions. Ann Am Thorac Soc. 2017;14(8):1305–1311. doi:10.1513/AnnalsATS.201611-903OC
   PubMed Web of Science ®Google Scholar
• Mahler DA, Waterman LA, Ward J, Gifford AH. Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate. J Aerosol Med Pulm Drug Deliv. 2014;27(2):103–109. doi:10.1089/jamp.2013.1038
   PubMed Web of Science ®Google Scholar
• de Boer AH, Hagedoorn P, Hoppentocht M, Buttini F, Grasmeijer F, Frijlink HW. Dry powder inhalation: past, present and future. Expert Opin Drug Deliv. 2017;14(4):499–512. doi:10.1080/17425247.2016.1224846
   PubMed Web of Science ®Google Scholar
• Self TH, Pinner NA, Sowell RS, Headley AS. Does it really matter what volume to exhale before using asthma inhalation devices? J Asthma. 2009;46(3):212–216. doi:10.1080/02770900802492087
   PubMed Web of Science ®Google Scholar
• Hanania NA, Wittman R, Kesten S, Chapman KR. Medical personnel’s knowledge of and ability to use inhaling devices. Metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest. 1994;105(1):111–116. doi:10.1378/chest.105.1.111
   PubMed Web of Science ®Google Scholar
• Chopra N, Oprescu N, Fask A, Oppenheimer J. Does introduction of new “easy to use” inhalational devices improve medical personnel’s knowledge of their proper use? Ann Allergy Asthma Immunol. 2002;88(4):395–400. doi:10.1016/S1081-1206(10)62371-X
   PubMed Web of Science ®Google Scholar
• Kesten S, Zive K, Chapman KR. Pharmacist knowledge and ability to use inhaled medication delivery systems. Chest. 1993;104(6):1737–1742. doi:10.1378/chest.104.6.1737
   PubMed Web of Science ®Google Scholar
• Capstick TG, Clifton IJ. Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma. Expert Rev Respir Med. 2012;6(1):91–101. doi:10.1586/ers.11.89
   PubMed Web of Science ®Google Scholar
• Azouz W, Chrystyn H. Clarifying the dilemmas about inhalation techniques for dry powder inhalers: integrating science with clinical practice. Prim Care Respir J. 2012;21(2):208–213. doi:10.4104/pcrj.2012.00010
   PubMedGoogle Scholar
• Newman SP. Aerosol deposition considerations in inhalation therapy. Chest. 1985;88(2 Suppl):152S–160S. doi:10.1378/chest.88.2_Supplement.152S
   PubMed Web of Science ®Google Scholar
• Clark AR, Weers JG, Dhand R. The confusing world of dry powder inhalers: it is all about inspiratory pressures, not inspiratory flow rates. J Aerosol Med Pulm Drug Deliv. 2020;33(1):1–11. doi:10.1089/jamp.2019.1556
   PubMed Web of Science ®Google Scholar
• Laube BL, Janssens HM, De jongh FHC, et al. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J. 2011;37:1308–1331.
   PubMed Web of Science ®Google Scholar
• Azouz W, Chetcuti P, Hosker HS, Saralaya D, Stephenson J, Chrystyn H. The inhalation characteristics of patients when they use different dry powder inhalers. J Aerosol Med Pulm Drug Deliv. 2015;28(1):35–42. doi:10.1089/jamp.2013.1119
   PubMed Web of Science ®Google Scholar
• Vitacca M, Paneroni M, Fracassi M, et al. Inhaler technique knowledge and skills before and after an educational program in obstructive respiratory disease patients: a real-life pilot study. Pulmonology. 2020. doi:10.1016/j.pulmoe.2020.04.010
   Google Scholar
• Duarte-de-araujo A, Teixeira P, Hespanhol V, Correia-de-sousa J. COPD: misuse of inhaler devices in clinical practice. Int J Chron Obstruct Pulmon Dis. 2019;14:1209–1217. doi:10.2147/COPD.S178040
   PubMed Web of Science ®Google Scholar
• Ghosh S, Pleasants RA, Ohar JA, Donohue JF, Drummond MB. Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD. Int J Chron Obstruct Pulmon Dis. 2019;14:585–595. doi:10.2147/COPD.S195438
   PubMed Web of Science ®Google Scholar
• Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/S0140-6736(18)30841-9
   PubMed Web of Science ®Google Scholar
• Huang K, Yang T, Xu J, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Lancet. 2019;394(10196):407–418. doi:10.1016/S0140-6736(19)31147-X
   PubMed Web of Science ®Google Scholar
• Wu Y, Cheng Y, You Y. Survey of inhalation use in 130 hospitals in 24 provinces and cities from 2011 to 2015 (in Chinese). Herald Med. 2017;36(12).
   Google Scholar